🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Massachusetts › Boston

Etid klinik pou Maladi Entestinal Anflamatwa nan Boston, MA

15 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07033208

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 003, Boston
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Boston Childrens Hospital, Boston
Laj 2 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT05923073

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Ap rekriteFaz 3
  • Boston Children's Hospital, Boston
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Ap rekriteFaz 3
  • Boston Children's Hospital, Boston
Laj 2 a 17 · Tout sèks · Mizajou Aug 24, 2026 · NCT05509777

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ap rekriteEtid obsèvasyon
  • Brigham and Women's Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

Low Dose IL-2 for the Treatment of Crohn's Disease

Ap rekriteFaz 1/2
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Laj 12 a 80 · Tout sèks · Mizajou Aug 3, 2026 · NCT04263831

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Ap rekriteFaz 4
  • Boston Children's Hospital, Boston
Laj 6 a 17 · Tout sèks · Mizajou May 27, 2026 · NCT05781152

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 14 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT05332639

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 18 a 75 · Tout sèks · Mizajou Dec 16, 2025 · NCT07219537

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

Ap rekrite
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Nov 6, 2025 · NCT07168499

Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Boston Children's Hospital, Boston
Laj 13 a 20 · Tout sèks · Mizajou Oct 30, 2025 · NCT04508088

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Ap rekriteEtid obsèvasyon
  • Boston Children's Hospital, Boston
Laj 5 a 25 · Tout sèks · Mizajou Mar 3, 2025 · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 14 ak plis · Tout sèks · Mizajou Dec 20, 2024 · NCT06655415

Etid Maladi Entestinal Anflamatwa nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.